Our results demonstrate that measuring the expression of the focal adhesion genes PTK2B, LYN and PTK2 can refine the intermediate-risk cytogenetic classification of AML, which could improve the stratification of the heterogeneous cytogenetic IR-AML, based on current markers. Here, PTK2 is linked to acute myeloid leukemia.